Navigation Links
Abbott Awards CFCareForward Scholarships to Two Students Living With Cystic Fibrosis Pursuing Undergraduate and Graduate Degrees
Date:10/25/2011

ABBOTT PARK, Ill., Oct. 25, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today awarded $19,000 scholarships to two exceptional students – one undergraduate and one graduate – living with cystic fibrosis (CF).  Lauren Meiss, winner of the Thriving Undergraduate Student Scholarship, and Emily Kramer-Golinkoff, winner of the Thriving Graduate Student Scholarship, were among 40 finalists living with CF who were eligible to receive the two scholarships through the CFCareForward program this year.  Lauren and Emily were chosen based on their outstanding academic achievements, community service, and artistic talent, as well as the number of votes they received during a public voting period.

"Abbott is proud to support Lauren and Emily as they pursue their goals for higher education," said Jim Hynd, divisional vice president, Metabolics, GI Care and Dyslipidemia, Abbott.  "Along with all of this year's CFCareForward Scholarship recipients, these students are an inspiration to others living with CF, and to anyone facing a health challenge."

Earlier this year, 40 students with CF were selected from hundreds of applicants to receive $2,500 scholarships for use during the 2011-2012 academic year.  Essays, poetry, artwork and personal and academic achievements were among the elements that comprised each of the students' profiles, which were featured on the CFCareForward Scholarship website.  Members of the public used the profiles to decide which student would earn their vote to win one of two Thriving Student Scholarships.

"As a student living with CF, it's very important to me to express my talents, enjoy life, and show others what's possible," said Phoenix, AZ native and Thriving Undergraduate Student Scholarship recipient, Lauren Meiss.  "The financial support from th
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
2. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
3. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
4. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
5. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
6. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
7. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
8. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
9. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
10. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... EASTON, Mass. , Sept. 19, 2014 /PRNewswire/ ... "Company") today announced it has received and approved ... Barozyme HT48 instruments and has begun to manufacture ... the first instrument will be ready for shipment ... be built and released at a rate of ...
(Date:9/19/2014)... and ORLANDO, Fla. , ... supporting Inspire therapy continues to grow, with the publication ... published on-line in Otolaryngology – Head and ... causes a worsening of both objective and subjective measures ... directly attribute Inspire therapy for the reduction in obstructive ...
(Date:9/19/2014)... , Sept. 19, 2014 Intarcia ... interim clinical data for its lead candidate ITCA 650 ... patients with high baseline HbA1c levels at the 50 ... the Study of Diabetes (EASD). Data from the open-label, ... levels of blood sugar in patients with poorly controlled ...
Breaking Medicine Technology:Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
... 13 An 80-year-old lung cancer patient has become ... using a new linear accelerator that can deliver precise ... Center carried out the treatment last week, becoming only ... using TrueBeam™ from Varian Medical Systems (NYSE: VAR). ...
... CANTON, Ohio, Sept. 13 AultCare has been ... in partnership with Cardiocom, released a white paper ... The paper describes the structure of ... and patient. Improved patient self-management has resulted in ...
Cached Medicine Technology:Leading Dutch Cancer Center Commences Treatments Using New TrueBeam from Varian Medical Systems 2Leading Dutch Cancer Center Commences Treatments Using New TrueBeam from Varian Medical Systems 3AultCare/Cardiocom® White Paper Shows Telehealth Services Reduce ER Visits and Inpatient Stays for Patients 2
(Date:9/19/2014)... Researchers at Jacksonville,s campus of Mayo Clinic have ... say contributes to both overproduction of toxic protein in ... well as loss of communication between neurons both ... study, in the online issue of Neuron ... defect with drugs "may rejuvenate or rescue this pathway," ...
(Date:9/19/2014)... Recently, Top10BestSEOHosting.com has compared many professional ... Web Hosting and Bluehost are the best VPS ... to most people, VPS (Virtual Private Server) is ... into many servers, each of which has the ... dedicated computer,” the manager of Top10BestSEOHosting.com says. ...
(Date:9/19/2014)... 2014 BCC Research reveals in its ... MARKETS , the global market for human antifungal therapeutics ... 2018, with a five-year compound annual growth rate (CAGR) ... at a steady 3.8% CAGR. , Given the current ... coupled with the incidence of increasing mortality and the ...
(Date:9/19/2014)... receive any palliative care, reveals new research to be ... in Madrid, Spain, 26-30 September. The findings are astonishing ... new oncology centres in Europe, Canada, South America and ... Designated Centre of Integrated Oncology and Palliative Care., , ... the Institute of Oncology Bucharest, Romania, member of the ...
(Date:9/19/2014)... Dallas, TX (PRWEB) September 19, 2014 ... which introduces a traditional Scandinavian style of ... United States. Much like Diet Doc’s medical ... Diet emphasizes cooking and eating good food ... diet also focuses on teaching patients to ...
Breaking Medicine News(10 mins):Health News:Mayo researchers reveal pathway that contributes to Alzheimer's disease 2Health News:Top10BestSEOHosting.com: JustHost is One of the Best VPS Suppliers in 2014 2Health News:Global Market for Human Antifungal Therapeutics to Reach Nearly $13.9 Billion in 2018; Over-The-Counter (OTC) Segment Growing At 3.8% CAGR 2Health News:Global Market for Human Antifungal Therapeutics to Reach Nearly $13.9 Billion in 2018; Over-The-Counter (OTC) Segment Growing At 3.8% CAGR 3Health News:Patients with advanced, incurable cancer denied palliative care 2Health News:Patients with advanced, incurable cancer denied palliative care 3Health News:Patients with advanced, incurable cancer denied palliative care 4Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 2Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 3Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 4
... People are increasingly going in for homeopathic treatment in ... reasons behind the shift, said doctors at a homeopathic ... more people are following homeopathy, even for cancer treatment ... or chronic diseases, even after receiving chemotherapy treatment, many ...
... is set to take off in Britain amidst bouquets and ... manufacturing//, will seek to realize the goal of providing intelligent ... each serving. ,The GDA campaign has the support ... with well known super markets - Tesco, Somerfield and Morrison. ...
... is a boon for the kith and kin of those ... is currently available in 33 countries all over the world ... vaccine was formed by Professor Ian Frazer, Director of the ... Australia who in all likelihood could be strong contender for ...
... Dr. Martijn B.A. van Doorn of the Center for Human ... revealed that garlic has no significance// in controlling their cholesterol ... was published in the American Journal of Clinical Nutrition puts ... on garlic and its positive influence on heart diseases. ...
... niggling sensation that runs you down, and cannot be wished ... on the one it descends//. The government also coughs up ... common infection- deluge in the olfactory organ! ... so strategies to wrap up a cold quickly, has been ...
... to good to be true and that which will lend ... cell research//. ,Stem cells are cells capable ... could develop into any type of tissue or organ. Hence ... finding a cure for incurable diseases like Alzheimer’s, Parkinson’s, diabetes ...
Cached Medicine News:Health News:Homeopathy can Cure Many Chronic Diseases 2Health News:New Source of Stem Cells Discovered 2
The Wire Cutters are designed to cut Kirschner wires up to 2.5 mm diameter easily and smoothly. They are particularly useful for external fixation applications. The Wire Cutters shear fixation wires ...
The osteotome shafts are manufactured with stainless steel and are available both straight and curved in 1/4" and 1/2" sizes....
... Pulse CDC Compact Cardiac Digital Camera is a ... open, patient-friendly gantry, and provides full sized fields ... into your clinic you need a flexible system ... Find out how the Pulse reduces the ...
... is the ultimate objective of neurovascular treatment ... Detachable Coils, occlusion is only the beginning... ... intended for embolization of those intracranial aneurysms ... location, or the patient's general medical condition ...
Medicine Products: